114 related articles for article (PubMed ID: 16704210)
1. Folate immobilized and PEGylated adenovirus for retargeting to tumor cells.
Oh IK; Mok H; Park TG
Bioconjug Chem; 2006; 17(3):721-7. PubMed ID: 16704210
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus.
Park JW; Mok H; Park TG
Biochem Biophys Res Commun; 2008 Feb; 366(3):769-74. PubMed ID: 18083120
[TBL] [Abstract][Full Text] [Related]
3. Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells.
Jung Y; Park HJ; Kim PH; Lee J; Hyung W; Yang J; Ko H; Sohn JH; Kim JH; Huh YM; Yun CO; Haam S
J Control Release; 2007 Nov; 123(2):164-71. PubMed ID: 17854941
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate.
Cho KC; Kim SH; Jeong JH; Park TG
Macromol Biosci; 2005 Jun; 5(6):512-9. PubMed ID: 15948228
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
7. Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction.
Park JW; Mok H; Park TG
J Control Release; 2010 Mar; 142(2):238-44. PubMed ID: 19913577
[TBL] [Abstract][Full Text] [Related]
8. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
Hwa Kim S; Hoon Jeong J; Joe CO; Gwan Park T
J Control Release; 2005 Apr; 103(3):625-34. PubMed ID: 15820409
[TBL] [Abstract][Full Text] [Related]
9. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
10. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
[TBL] [Abstract][Full Text] [Related]
11. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
Cheng H; Zhu JL; Zeng X; Jing Y; Zhang XZ; Zhuo RX
Bioconjug Chem; 2009 Mar; 20(3):481-7. PubMed ID: 19191579
[TBL] [Abstract][Full Text] [Related]
12. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
13. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Liu M; Xu W; Xu LJ; Zhong GR; Chen SL; Lu WY
Bioconjug Chem; 2005; 16(5):1126-32. PubMed ID: 16173789
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of folate conjugated polymer micelles against different tumor cells.
Zhao H; Yung LY
Int J Pharm; 2008 Feb; 349(1-2):256-68. PubMed ID: 17850996
[TBL] [Abstract][Full Text] [Related]
17. PEGylated adenovirus for targeted gene therapy.
O'Riordan CR; Song A
Methods Mol Biol; 2008; 434():133-60. PubMed ID: 18470643
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis.
Chul Cho K; Hoon Jeong J; Jung Chung H; Joe CO; Wan Kim S; Gwan Park T
J Control Release; 2005 Nov; 108(1):121-31. PubMed ID: 16139916
[TBL] [Abstract][Full Text] [Related]
19. Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression.
Luten J; van Steenbergen MJ; Lok MC; de Graaff AM; van Nostrum CF; Talsma H; Hennink WE
Eur J Pharm Sci; 2008 Mar; 33(3):241-51. PubMed ID: 18207707
[TBL] [Abstract][Full Text] [Related]
20. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
